Chelsea Counsel Company’s Allergan plc AGN Stock Holding History

Chelsea Counsel Company’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,104	Closed	-$226K	–	87
2017 Q3	$226K	Hold	1,104	–	–	0.11%	75
2017 Q2	$268K	Hold	1,104	–	–	0.14%	73
2017 Q1	$264K	Sell	1,104 -1,500	-58%	-$349K	0.14%	76
2016 Q4	$547K	Hold	2,604	–	–	0.29%	59
2016 Q3	$600K	Sell	2,604 -1,500	-37%	-$367K	0.31%	54
2016 Q2	$948K	Hold	4,104	–	–	0.43%	47
2016 Q1	$1.1M	Hold	4,104	–	–	0.35%	52
2015 Q4	$1.28M	Sell	4,104 -200	-5%	-$59.5K	0.39%	52
2015 Q3	$1.17M	Sell	4,304 -700	-14%	-$215K	0.28%	57
2015 Q2	$1.52M	Buy	5,004 +2,883	+136%	+$860K	0.34%	51
2015 Q1	$631K	Buy	2,121 +921	+77%	+$263K	0.14%	72
2014 Q4	$309K	Buy	+1,200	New	+$300K	0.06%	109

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Chelsea Counsel Company's AGN Position: Q4 2017 in Review

Chelsea Counsel Company sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,104 shares — an estimated $226K sold.

Chelsea Counsel Company first reported a position in AGN in Q4 2014 and held it in 12 quarters. The position peaked at $1.52M in Q2 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

Chelsea Counsel Company reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
Chelsea Counsel Company sold 1,104 Allergan plc shares in Q4 2017, an estimated $226K.
Chelsea Counsel Company first reported a position in Allergan plc in Q4 2014 and held it in 12 quarters.
Chelsea Counsel Company's Allergan plc position peaked at $1.52M in Q2 2015.
1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Chelsea Counsel Company's 13F filing for Q4 2017, filed 12 Jan 2018.